Search
DEEN
more info

Contact:
Phone:+49 0761 1514 440Fax:+49 0761 1514 460Email:info[at]falkfoundation.org

    Falk Gastro Review Journal

    Current science, compiled for you from the multitude of scientific publications – this is the Falk Gastro Review Journal.

    Dunkel- bis hellblaue Grafik einer Tonspur-Frequenz auf orangem Hintergund.

    The latest issues

    Edition 4/2024

    read more

    Edition 3/2024

    read more

    Edition 2/2024

    read more

    Find here all FGR publications since mid-2022 selected and reviewed from international medical journals. Click here above to browse the individual quarterly issues or use the filters below or click chronologically through all articles.

    All articles

    Esophagus to Small Intestine

    Steroid-free deep remission at 1 year does not prevent Crohn’s disease progression: Long-term data from the TAILORIX trial

    Clin Gastroenterol Hepatol. 2022;20(9):2074–82

    Laharie D, D’Haens G, Nachury M, Lambrecht G, Bossuyt P, Bouhnik Y, Louis E, van der Woude CJ, Buisson A, Van Hootegem P, Allez M, Filippi J, Brixi H, Gilletta C, Picon L, Baert F, Vermeire S, Duveau N, Peyrin-Biroulet L

    Go to article

    Esophagus to Small Intestine

    Subclinical persistent inflammation as risk factor for Crohn’s disease progression: Findings from a prospective real-world study of 2 years

    Clin Gastroenterol Hepatol. 2022;20(9):2059–73.e7

    Magro F, Magalhães D, Patita M, Arroja B, Lago P, Rosa I, Tavares de Sousa H, Ministro P, Mocanu I, Vieira A, Castela J, Moleiro J, Roseira J, Cancela E, Sousa P, Portela F, Correia L, Santiago M, Dias S, Alves C, Afonso J, Danese S, Peyrin-Biroulet L, Dias CC; Portuguese Group of Studies in IBD (GEDII)

    Go to article

    Esophagus to Small Intestine

    Short-term anti-TNF therapy with surgical closure versus anti-TNF therapy in the treatment of perianal fistulas in Crohn’s disease (PISA-II): A patient preference randomized trial

    Lancet Gastroenterol Hepatol. 2022;7(7):617–26

    Meima-van Praag EM, van Rijn KL, Wasmann KATGM, Snijder HJ, Stoker J, D‘Haens GR, Gecse KB, Gerhards MF, Jansen JM, Dijkgraaf MGW, van der Bilt JDW, Mundt MW, Spinelli A, Danese S, Bemelman WA, Buskens CJ

    Go to article

    Colon to Rectum

    Pregnancy outcomes following periconceptional or gestational exposure to ustekinumab: Review of cases reported to the manufacturer’s Global Safety Database

    Aliment Pharmacol Ther. 2022;56(3):477–90

    Mahadevan U, Naureckas S, Tikhonov I, Wang Y, Lin CB, Geldhof A, van der Woude CJ

    Go to article

    Colon to Rectum

    Meat intake is associated with a higher risk of ulcerative colitis in a large European prospective cohort study

    J Crohns Colitis. 2022;16(8):1187–96

    Dong C, Chan SSM, Jantchou P, Racine A, Oldenburg B, Weiderpass E, Heath AK, Tong TYN, Tjønneland A, Kyrø C, Bueno de Mesquita B, Kaaks R, Katzke VA, Bergman MM, Boeing H, Palli D, Masala G, Tumino R, Sacerdote C, Colorado-Yohar SM, Sánchez MJ, Grip O, Lindgren S, Luben R, Huybrechts I, Gunter MJ, Mahamat-Saleh Y, Boutron-Ruault MC, Carbonnel F

    Go to article

    Colon to Rectum

    Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: Results from 3 phase 3, multicenter, double-blind, randomized trials

    Lancet. 2022;399(10341):2113–28

    Danese S, Vermeire S, Zhou W, Pangan AL, Siffledeen J, Greenbloom S, Hébuterne X, D‘Haens G, Nakase H, Panés J, Higgins PDR, Juillerat P, Lindsay JO, Loftus EV, Jr., Sandborn WJ, Reinisch W, Chen MH, Sanchez Gonzalez Y, Huang B, Xie W, Liu J, Weinreich MA, Panaccione R

    Go to article

    Colon to Rectum

    Exposure to corticosteroids in pregnancy is associated with adverse perinatal outcomes among infants of mothers with inflammatory bowel disease: Results from the PIANO registry

    Gut. 2022;71(9):1766–72

    Odufalu FD, Long M, Lin K, Mahadevan U; PIANO Investigators from the Crohn’s and Colitis Foundation (CCF) Clinical Research Alliance recruited patients for their respective centers for participant enrollment

    Go to article

    Colon to Rectum

    AJM300 (carotegrast methyl), an oral antagonist of α4-integrin, as induction therapy for patients with moderately active ulcerative colitis: A multicenter, randomized, double-blind, placebo-controlled, phase 3 study

    Lancet Gastroenterol Hepatol. 2022;7(7):648–57

    Matsuoka K, Watanabe M, Ohmori T, Nakajima K, Ishida T, Ishiguro Y, Kanke K, Kobayashi K, Hirai F, Watanabe K, Mizusawa H, Kishida S, Miura Y, Ohta A, Kajioka T, Hibi T; AJM300 Study Group

    Go to article

    Colon to Rectum

    Oral fluconazole therapy in patients with active ulcerative colitis who have detectable Candida in the stool: A double-blind randomized placebo-controlled trial

    J Clin Gastroenterol. 2022;56(8):705–11

    Jena A, Dutta U, Shah J, Sharma V, Prasad KK, Shivaprakash RM, Mandavdhare HS, Samanta J, Sharma P, Popli P, Sharma AK, Sinha SK, Chakrabarti A, Kochhar R

    Go to article